CTLA4 and hypophysitis: The varying incidence rates of ICI-induced hypophysitis (IIH) have been attributed to the different mechanisms of action of the ICI: antibodies that block CTLA-4 enhance T-cell priming, while those that block PD-1/PD-L1 seem to enhance an existing CD8 T-cell response [2,59].